SkinBioTherapeutics

SBTX · AIM · Health Care · mcap £14m · 5.3p

Beta Briefing, track record and signals & risks are not ready for SkinBioTherapeutics yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Financials · LTM to 31 Dec 25

Source: results 08 Jun 26 ↗

Revenue: £4.5m
Operating profit: −£2.1m
Net income: −£1.5m
Free cash flow: −£2.2m
Net cash: £2.5m
Market cap: £13.8m
EV / EBIT: –
FCF yield: −16.1%
Price / book: 1.7×

Latest half-year · H1 Dec 25 vs H1 Dec 24 results 08 Jun 26 ↗

Revenue: £2.2m
Operating profit: −£1.0m
Net income: −£794k
Cash from operations: −£1.5m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

As reported Key figures

Income statement Balance sheet Cash flow

Annual Half-yearly

Every line as the company printed it, newest first – each period in the latest version the company published (restated figures where a later report restated them), in its own currency and units. Italic = calculated (H2 = full year − first half). The column headings link to the announcements.

Latest report: H1 Dec 25 (six months to 31 Dec 25), published 08 Jun 26 · read the results ↗

	FY Jun 25 source	FY Jun 24 source
Continuing Operations
Revenue	4,638,147	1,208,669
Cost of Sales	(1,778,867)	(525,631)
Gross Profit	2,859,280	683,038
Selling and distribution costs	(293,375)	(170,597)
Research and development	(127,347)	(562,911)
Other administrative expenses	(3,561,693)	(2,854,662)
Total operating expenses	(3,982,415)	(3,588,170)
Loss from operations	(1,123,135)	(2,905,132)
Finance costs	(91,981)	(43,760)
Gain on remeasurement of contingent consideration	500,000	-
Loss before taxation	(715,116)	(2,948,892)
Taxation	18,863	72,902
Loss for the year	(696,253)	(2,875,990)
Other comprehensive income	-	-
Total comprehensive loss for the year	(696,253)	(2,875,990)
Basic and diluted loss per share (pence)	(0.31)	(1.54)

	H1 Dec 25 source	H2 Jun 25 calc.	H1 Dec 24 source
Continuing operations
Revenue	4,638,147	5,407,147	(769,000)
Cost of sales	(1,778,867)	(1,778,867)	-
Gross profit	2,859,280	3,628,280	(769,000)
Selling and distribution	(293,375)	–	-
Research and development	(127,347)	(127,347)	-
Operating expenses	(3,561,693)	–	(233,675)
Loss from operations	(1,123,135)	(120,460)	(1,002,675)
Finance costs	(91,981)	(91,981)	-
Gain on remeasurement of contingent consideration	500,000	500,000	-
Loss before taxation	(715,116)	287,559	(1,002,675)
Taxation	18,863	63,149	(44,286)
Loss for the period	(696,253)	–	(1,046,961)
Total comprehensive loss for the period	(696,253)	–	(1,046,961)
Basic and diluted loss per share (pence)	(0.31)	0.46	(0.77)
1. Removal of Royalty income (see above)
2. Board bonuses, consultancy costs and amortisation of IP (see above)
3. Deferred tax adjustment (see above)
Restated Statement of Financial Position as at 30 June 2025
As previously reported Prior year adjustment As restated
£ £ £
ASSETS
Non-current assets
Property, plant and equipment	356,291	–	-
Right-of-use assets	372,057	–	-
Goodwill	2,419,640	–	-
Intangible assets	1,869,485	–	(26,586)
Total non-current assets	5,017,473	–	(26,586)
Current assets
Inventories	800,154	–	-
Trade and other receivables	1,528,628	–	(769,000)
Cash and cash equivalents	4,779,433	–	-
Total current assets	7,108,215	–	(769,000)
Total assets	12,125,688	–	(795,586)
EQUITY AND LIABILITIES
Equity
Capital and reserves
Called up share capital	2,587,794	–	-
Share premium	21,087,900	–	-
Other reserves	438,589	–	-
Accumulated deficit	(14,695,186)	–	(646,650)
Total equity	9,419,097	–	(646,650)
Liabilities
Non-current liabilities
Lease liabilities	281,354	–	-
Long term loans	600,000	–	-
Deferred tax	356,024	–	(356,024)
Total non-current liabilities	1,237,378	–	(356,024)
Current liabilities
Trade and other payables	1,072,919	–	207,086
Corporation tax payable	34,182	–	-
Lease liabilities	112,112	–	-
Deferred consideration	250,000	–	-
Total current liabilities	1,469,213	–	207,086
Total liabilities	2,706,591	–	(148,937)
Total equity and liabilities	12,125,688	–	(795,586)
1. Amortisation of intangibles (see above)
2. Accrued royalty income (see above)
3. Deferred tax adjustment (see above)
4. Board bonus accrual and consultancy costs (see above)
5. Deferred tax adjustment (see above)
3. Revenue and Segmental Reporting
The Group has the following reportable operating segments
3.1 Segment Results
6 months to 31 Dec 2025
Products Services Corporate Eliminations* Total
£ £ £ £ £
Sales	-	–	(183,588)
Cost of Sales	-	–	183,588
Gross Profit	-	–	-
Depreciation	(21,759)	–	-
Amortisation	-	–	-
Overheads	(1,000,262)	–	-
Operating profit	(1,022,021)	–	-
Interest	(13,237)	–	(23,189)
Gain on remeasurement	250,000	–	250,000
Loss before tax	(794,259)	–	–
Non-current assets	684,412	–	-
Current assets	4,156,816	–	-
Current liabilities	(243,354)	–	-
Non-current liabilities	(600,000)	–	-
Net Assets	3,997,874	–	-
6 months to 31 Dec 2024
Products Services Corporate Eliminations* Total
£ £ £ £ £
Sales	-	–	-
Cost of Sales	-	–	-
Gross Profit	-	–	-
Depreciation	(44,040)	–	-
Amortisation	-	–	-

	31 Dec 25 source	30 Jun 25 source	30 Jun 24 source
ASSETS
Non-current assets
Property, plant and equipment	356,791	356,291	44,357
Right-of-use assets	314,369	372,057	72,012
Goodwill	2,419,640	2,419,640	2,038,325
Intangible assets	1,705,588	1,869,485	1,388,959
Total non-current assets	4,796,388	5,017,473	3,543,653
Current assets
Inventories	925,204	800,154	472,419
Trade and other receivables	757,905	1,528,628	398,088
Cash and cash equivalents	3,124,689	4,779,433	800,904
Total current assets	4,807,798	7,108,215	1,671,411
Total assets	9,604,186	12,125,688	5,215,064
EQUITY AND LIABILITIES
Equity
Capital and reserves
Called up share capital	2,587,794	2,587,794	2,022,552
Share premium	21,087,900	21,087,900	14,507,673
Share based payment reserves	–	438,589	438,589
Other reserves	438,589	–	–
Accumulated deficit	(16,136,094)	(14,695,186)	(13,998,933)
Total equity	7,978,189	9,419,097	2,969,881
Liabilities
Non-current liabilities
Lease liabilities	242,670	281,354	39,861
Deferred consideration	–	-	250,000
Borrowings	–	600,000	-
Long term loans	600,000	–	–
Contingent consideration	-	–	–
Deferred tax	-	356,024	150,624
Total non-current liabilities	842,670	1,237,378	440,485
Current liabilities
Trade and other payables	652,650	1,072,919	498,560
Corporation tax payable	34,182	34,182	27,257
Lease liabilities	96,495	112,112	38,881
Convertible loan	–	-	740,000
Deferred consideration	–	250,000	500,000
Contingent consideration	-	–	–
Total current liabilities	783,327	1,469,213	1,804,698
Total liabilities	1,625,997	2,706,591	2,245,183
Total equity and liabilities	9,604,186	12,125,688	5,215,064

	31 Dec 25 source	30 Jun 25 source	31 Dec 24 source	30 Jun 24 source
ASSETS
Non-current assets
Property, plant and equipment	356,791	356,291	421,325	44,357
Right-of-use assets	314,369	372,057	56,797	72,012
Goodwill	2,419,640	2,419,640	2,419,640	2,038,325
Intangible assets	1,705,588	1,869,485	1,932,453	1,388,959
Total non-current assets	4,796,388	5,017,473	4,830,215	3,543,653
Current assets
Inventories	925,204	800,154	828,033	472,419
Trade and other receivables	757,905	1,528,628	501,821	398,088
Cash and cash equivalents	3,124,689	4,779,433	1,236,977	800,904
Total current assets	4,807,798	7,108,215	2,566,831	1,671,411
Total assets	9,604,186	12,125,688	7,397,046	5,215,064
EQUITY AND LIABILITIES
Equity
Capital and reserves
Called up share capital	2,587,794	2,587,794	2,284,359	2,022,552
Share premium	21,087,900	21,087,900	16,797,820	14,507,673
Share based payment reserves	–	438,589	–	438,589
Other reserves	438,589	–	438,589	–
Accumulated deficit	(16,136,094)	(14,695,186)	(14,781,863)	(13,998,933)
Total equity	7,978,189	9,419,097	4,738,905	2,969,881
Liabilities
Non-current liabilities
Lease liabilities	242,670	281,354	19,812	39,861
Deferred consideration	–	-	–	250,000
Borrowings	–	600,000	–	-
Long term loans	600,000	–	956,543	–
Contingent consideration	-	–	250,000	–
Deferred tax	-	356,024	-	150,624
Total non-current liabilities	842,670	1,237,378	1,226,355	440,485
Current liabilities
Trade and other payables	652,650	1,072,919	723,340	498,560
Corporation tax payable	34,182	34,182	158,319	27,257
Lease liabilities	96,495	112,112	50,127	38,881
Convertible loan	–	-	–	740,000
Deferred consideration	–	250,000	–	500,000
Contingent consideration	-	–	500,000	–
Total current liabilities	783,327	1,469,213	1,431,786	1,804,698
Total liabilities	1,625,997	2,706,591	2,658,141	2,245,183
Total equity and liabilities	9,604,186	12,125,688	7,397,046	5,215,064

	FY Jun 25 source	FY Jun 24 source
Cash flows from operating activities
Loss before tax for the period Net interest	(2,948,892)	36,816
Depreciation of property, plant and equipment	58,385	49,260
Right-of-use assets depreciation and interest	122,206	43,345
Loss on disposal of tangible assets	28,195	-
Gain on deferred consideration reversal	(500,000)	-
Amortisation of IP	246,004	83,368
Total cash flows from operating activities	(695,103)	(2,736,103)
Changes in working capital
Decrease/(increase) in inventories	14,177	96,419
(lncrease)/decrease in trade and other receivables	(752,283)	166,842
(Decrease)/increase in trade and other payables	172,351	(436,019)
Cash Used In operations	(565,755)	(172,758)
Taxation paid	25,788	182,545
Net cash used in operating activities	(1,235,070)	(2,726,316)
Investing activities
Purchase of property, plant and equipment	(6,300)	(14,959)
Purchase of IP	(152,530)	(169,996)
Purchase of right-of-use assets	-	(13,214)
Cash consideration	(1,462,530)	(1,598,423)
Deferred consideration	-	(500,000)
Net cash used in investing activities	(1,621,360)	(2,296,592)
Cash flows from financing activities
Net proceeds from issue of shares Net amounts raised from convertible loan	3,119,553	1,472,000
Net amounts raised from borrowings	950,000	-
Interest paid	(62,983)	(36,816)
Lease payments made	(107,527)	(42,759)
Net cash generated by/(used in) financing activities	6,834,959	4,511,978
Net increase in cash and cash equivalents	3,978,529	(510,930)
Cash and cash equivalents at the beginning of the period	800,904	1,311,834
Cash and cash equivalents at the end of the period	4,779,433	800,904

	H1 Dec 25 source	H2 Jun 25 calc.	H1 Dec 24 source
Cash flows from operating activities
Loss before tax for the period	(794,259)	–	(1,041,301)
Net interest	22,028	–	-
Depreciation of property, plant and equipment	21,079	32,197	26,188
Right-of-use assets depreciation and interest	72,117	104,354	17,852
Loss on disposal of tangible assets	-	28,195	-
Gain on deferred consideration reversal	(250,000)	(500,000)	-
Amortisation of IP	171,952	135,688	110,316
Total cash flows from operating activities	(757,083)	191,842	(886,945)
Changes in working capital
Decrease/(Increase) in inventories	(125,050)	23,744	(9,567)
Decrease/(Increase) in trade and other receivables	1,723	–	166,178
Increase/(decrease) in trade and other payables	(627,355)	242,992	(70,641)
Cash generated by/(used in) operations	(750,682)	–	85,970
Taxation received/(paid)	-	–	-
Net cash generated by/(used in) operating activities	(1,507,765)	–	(800,975)
Cash flows from investing activities
Purchase of property, plant and equipment	(21,579)	(6,300)	-
Purchase of IP	(34,641)	(71,787)	(80,743)
Purchase of right-of-use assets	-	2,637	(2,637)
Cash consideration	-	(45,463)	(1,417,067)
Net cash used in investing activities	(56,220)	(120,913)	(1,500,447)
Cash flows from financing activities
Net proceeds from issue of shares	-	–	1,811,953
Net amounts raised from loans	-	–	950,000
Interest paid	(22,028)	(60,742)	(2,241)
Lease payments made	(68,730)	(85,310)	(22,217)
Net cash gained by financing activities	(90,758)	–	2,737,495
Net increase/(decrease) in cash and cash equivalents	(1,654,744)	3,542,456	436,073
Cash and cash equivalents at the beginning of the period	4,779,433	-	800,904
Cash and cash equivalents at the end of the period	3,124,689	3,542,456	1,236,977

	LTM Dec 25	FY Jun 25	FY Jun 24
Revenue to operating profit
Revenue	4.5	3.9^r	1.2
Gross profit	2.4	2.1^r	0.7
Operating profit	(2.1)	(2.1)^r	(2.9)
Depreciation (owned assets)	0.1	0.1	0.0
Amortisation	0.3	0.3	0.1
Operating profit to net income
Finance costs	(0.1)	(0.1)	(0.0)
Profit before tax	(1.5)	(1.7)^r	(2.9)
Tax	(0.0)	(0.0)	0.1
Net income (owners)	(1.5)	(1.7)^r	(2.9)
Per share
EPS basic	(0.6p)	(0.8p)	(1.5p)
EPS diluted	(0.6p)	(0.8p)	(1.5p)

	H1 Dec 25	vs H1 Dec 24	H2 Jun 25	H1 Dec 24
Revenue to operating profit
Revenue	2.2	+37%	2.3	1.6
Gross profit	1.2	+37%	1.2	0.9
Operating profit	(1.0)	n/m	(1.1)	(1.0)
Depreciation (owned assets)	0.0	n/m	0.0	0.0
Amortisation	0.2	+56%	0.2	0.1
Operating profit to net income
Finance costs	(0.0)	n/m	(0.1)	(0.0)
Profit before tax	(0.8)	n/m	(0.7)	(1.0)
Tax	0.0	n/m	(0.0)	0.0
Net income (owners)	(0.8)	n/m	(0.7)	(1.0)
Per share
EPS basic	(0.3p)	–	(0.3p)	(0.5p)
EPS diluted	(0.3p)	–	(0.3p)	(0.5p)

	LTM Dec 25	FY Jun 25	FY Jun 24
Operating activities
Cash from operations	(1.9)	(1.2)	(2.7)
Interest paid	(0.1)	(0.1)	(0.0)
Tax paid	0.0	0.0	0.2
Investing activities
Capex (PP&E)	(0.0)	(0.0)	(0.0)
Capex (intangibles)	(0.1)	(0.2)	(0.2)
Financing activities
Lease principal paid	(0.2)	(0.1)	(0.0)
Shares issued	4.2	6.1	–

	H1 Dec 25	vs H1 Dec 24	H2 Jun 25	H1 Dec 24
Operating activities
Cash from operations	(1.5)	n/m	(0.4)	(0.8)
Interest paid	(0.0)	n/m	(0.1)	(0.0)
Tax paid	0.0	n/m	0.0	0.0
Investing activities
Capex (PP&E)	(0.0)	n/m	(0.0)	0.0
Capex (intangibles)	(0.0)	n/m	(0.1)	(0.1)
Financing activities
Lease principal paid	(0.1)	n/m	(0.1)	(0.0)
Shares issued	0.0	n/m	4.2	1.8

	31 Dec 25	30 Jun 25	30 Jun 24
Non-current assets
Goodwill	2.4	2.4	2.0
Other intangibles	1.7	1.8	1.4
Property, plant & equipment	0.4	0.4	0.0
Non-current assets	4.8	5.0	3.5
Current assets
Inventories	0.9	0.8	0.5
Trade receivables	0.8	0.8^r	0.4
Cash	3.1	4.8	0.8
Current assets	4.8	6.3^r	1.7
Total assets	9.6	11.3^r	5.2
Current liabilities
Trade payables	0.7	1.3^r	0.5
Borrowings, current	–	0.0	0.7
Lease liabilities, current	0.1	0.1	0.0
Current liabilities	0.8	1.7^r	1.8
Non-current liabilities
Borrowings, non-current	0.6	0.6	0.0
Lease liabilities, non-current	0.2	0.3	0.0
Non-current liabilities	0.8	0.9	0.4
Total liabilities	1.6	2.6^r	2.2
Equity
Total equity	8.0	8.8^r	3.0

	31 Dec 25	30 Jun 25	31 Dec 24	30 Jun 24
Non-current assets
Goodwill	2.4	2.4	2.4	2.0
Other intangibles	1.7	1.8	1.9	1.4
Property, plant & equipment	0.4	0.4	0.4	0.0
Non-current assets	4.8	5.0	4.8	3.5
Current assets
Inventories	0.9	0.8	0.8	0.5
Trade receivables	0.8	0.8^r	0.5	0.4
Cash	3.1	4.8	1.2	0.8
Current assets	4.8	6.3^r	2.6	1.7
Total assets	9.6	11.3^r	7.4	5.2
Current liabilities
Trade payables	0.7	1.3^r	0.7	0.5
Borrowings, current	–	0.0	–	0.7
Lease liabilities, current	0.1	0.1	0.1	0.0
Current liabilities	0.8	1.7^r	1.4	1.8
Non-current liabilities
Borrowings, non-current	0.6	0.6	1.0	0.0
Lease liabilities, non-current	0.2	0.3	0.0	0.0
Non-current liabilities	0.8	0.9	1.2	0.4
Total liabilities	1.6	2.6^r	2.7	2.2
Equity
Total equity	8.0	8.8^r	4.7	3.0

Read automatically from each results announcement. Check the source before relying on a figure.

Company filings. Not investment advice.